This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Impurities

Details about impurity identification and characterization.

Product

Resources

MedicinalProductDefinition	The drug product (Stelbat tablets, 20mg)
SubstanceDefinition	The documented impurities
Medication	Describes the batches of the product that underwent testing for impurities
Observation	The results of testing for impurities in the batches
Organization	The company/site that performed the testing, or manufactured the batch
DiagnosticReport	Contains all results as a group, with conclusions

Examples

CTD section synthetic source data samples (PDF):

• 3.2.P.5 Control of Drug Product
  • 3.2.P.5.5 Characterisation of Impurities

XML and JSON examples of synthetic quality data:

• Product Impurities example XML
• Product Impurities example JSON

HTML presentation example of synthetic quality data:

• Product Impurities example HTML - Note that HTML examples represent ways to create human-readable output using structured quality data (see section 1.2 Scope).

Substance

Resources

SubstanceDefinition	The substance itself and its impurities as substances
DocumentReference	Image files e.g. for molecular structure

Examples

CTD section synthetic source data samples (PDF):

• 3.2.S.3 Characterisation
  • 3.2.S.3.2 Impurities

XML and JSON examples of synthetic quality data:

• Substance Impurities example XML
• Substance Impurities example JSON

HTML presentation example of synthetic quality data:

• Substance Impurities example HTML - Note that HTML examples represent ways to create human-readable output using structured quality data (see section 1.2 Scope).

Profiles

See Artifacts Index: Domain Bundle Profiles